Back to Peptide Pedia
Longevity & Anti-Aging
Limited Research

Cardiogen

CARD

Peptide bioregulator studied in cardiac tissue.

Also known as: Ala-Glu-Asp-Arg bioregulator

Research dose range100 mcg daily (research models)
Route studiedSubcutaneous
Study durationShort courses (e.g., ~10–20 days)
Storage2–8 °C reconstituted

Overview

Cardiogen is a short peptide bioregulator studied in cardiac-tissue and cellular-aging research, part of the Khavinson bioregulator family.

Key research findings

A short peptide bioregulator studied for cardiovascular-tissue-specific signaling. Like other bioregulators, it is proposed to act at very low amounts to normalize tissue-specific gene expression in the heart and vasculature over short repeatable courses.

Mechanism of action

Studied for modulating gene expression associated with cardiac-cell maintenance and regeneration.

Molecular information

Weight~Few hundred Da
LengthShort peptide (2–4 amino acids)
TypeCardiac-targeted peptide bioregulator

Part of the short-peptide bioregulator family targeting cardiovascular tissue.

Pharmacokinetics

Peak: ~1 hourHalf-life: ~Short (minutes to hours)Cleared: ~24 hours
Peak · 1hHalf-life · 5h

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Cardiac-tissue research
  • Cellular-aging studies
  • Peptide-bioregulator investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Standard referenceAmount: 100 mcgFrequency: Once dailyRoute: Subcutaneous
Course referenceAmount: 100 mcgFrequency: Daily ~10–20 daysRoute: Subcutaneous

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Course (10–20 days)

    Bioregulator protocols emphasize short, repeatable courses rather than continuous use.

  2. Between courses

    Cardiovascular effects are proposed to persist via gene-regulatory normalization.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

Cartalax

Different target tissue; complementary in protocols.

Compatible

Prostamax

Different target tissue; complementary bioregulator.

Compatible

Epitalon

Complementary longevity bioregulator.

Compatible

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Short peptides are sensitive to heat and agitation.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved into a clear solution.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Generally reported as well tolerated in the bioregulator literature, which is largely from a single research lineage.
  • Independent replication outside the originating group is limited.

References & further reading

Short peptide bioregulators in cardiovascular tissue (review)

Preclinicalbioregulatorscardiac

Review of the short-peptide bioregulator concept and proposed cardiovascular tissue-specific signaling.

View study

Topics

bioregulatorcardiaclongevity

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Limited Research

Sparse published data; largely preliminary or anecdotal.

Quick reference
Dose range100 mcg daily (research models)
RouteSubcutaneous
DurationShort courses (e.g., ~10–20 days)
Storage2–8 °C reconstituted
Half-life~Short (minutes to hours)
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue